发明名称 |
Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof |
摘要 |
The invention relates generally to combination therapies comprising an endothelin A receptor (ET<SUB>A</SUB>) antagonist and a phosphodiesterase 5 (PDE5) inhibitor, pharmaceutical compositions comprising ET<SUB>A </SUB>antagonist and PDE5 inhibitor and methods of treating various disorders comprising administering an ET<SUB>A </SUB>antagonist and a PDE5 inhibitor. In particular, the combination therapies and pharmaceutical compositions are useful for the treatment and/or prevention of cardiac disorders such as pulmonary arterial hypertension (PAH).
|
申请公布号 |
US2006205733(A1) |
申请公布日期 |
2006.09.14 |
申请号 |
US20050211099 |
申请日期 |
2005.08.25 |
申请人 |
ENCYSIVE PHARMACEUTICALS |
发明人 |
DIXON RICHARD;KEYSER DONALD J. |
分类号 |
A61K31/519;A61K31/4025;A61K31/42;A61K31/4745;A61K31/513 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|